Epigenetic checkpoint control could boost T-Cell antitumour activity

Histone deacetylase 11 (HDAC11), an epigenetic enzyme, has been identified as a potential immunotherapeutic target. According to researchers based at George Washington University (GWU), HDAC11 is a negative regulator of T-cell function. Specifically, T...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2uzNv5z
via IFTTT